« Back
Home /
Anti-Bevacizumab Antibody, pAb, Rabbit

Anti-Bevacizumab Antibody, pAb, Rabbit

Manufacturer	GenScript
Category	Oncology Antibodies Primary Antibodies By Organ Lung Cancer Bladder Cancer Colorectal Cancer
Type	Antibody Polyclonal
Specific against	other
Amount	40 ug
Item no.	A01887-40
eClass 6.1	32160702
eClass 9.0	32160702
Available
Description	Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As angiogenesis inhibitor, Bevacizumab blocks angiogenesis by inhibiting vascular endothelial growth factor A (VEGF-A). GenScript Anti-Bevacizumab Antibody, pAb, Rabbit is produced from sera of a rabbit immunized with Bevacizumab.
Product Line	PL401_Primary Antibodies
Shipping Temperature	4
Storage	The lyophilized product remains stable up to 1 year at -20 C from date of receipt. Upon reconstitution, it can be stored for 2-3 weeks at 2-8 C or for up to 12 months at -20 C or below. Avoid repeated freezing and thawing cycles.
Storage Temperature	-20
Manufacturers Category	Antibodies
Manufacturers Product Line	Anti-Idiotype Antibodies
Product Origin	USA

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 40 ug

available

Delivery expected until 7/19/2024

Express Delivery: Save 2 days

Compare

Add to wishlist

Recommend by mail